Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzarán
      6. Gustavo A. Alcocer
      7. Alejandro Luna
      8. Alonso Camargo
      9. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Abraham Diaz
      6. Georgina Flores
      7. Pedro Herrera
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
    4. Attorneys / Engineers
      1. Emilio Albarrán
      2. Agustín Azcatl
      3. Alejandra Badillo
      4. Ignacio Burgoa
      5. Fernando Calderón
      6. Martha Celis
      7. Erwin Cruz
      8. Fernanda Díaz
      9. Luz Elena Elías
      10. Maria Fenton
      11. 12 more items...
    5. Firm Administration
    6. Directory
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. International Comparative Legal Guide: Trademarks 2013
        2. Altering the distinctive sign of a mark
        3. Filing reforms will save paper and money
        4. Getting the Deal Through -Trademarks 2013
        5. A new solution for trade mark filing errors
        6. Crossed wires: protecting medicines in Mexico
        7. New Trademark Examiner's Manual
        8. Supreme Court: individuals can register marks
        9. Use requirements
        10. Approach to composite marks changed, again
        11. 50 more items...
      2. Patent Law Articles
        1. PPH programmes in Mexico
        2. Patents rejected for lack of proof
        3. When copyrights and patents collide
        4. Design protection can be broadened
        5. Maximising IP rights in the life sciences industry
        6. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        7. Getting the Deal Through - Patents 2012
        8. Surge of Patent Application Final Rejections Provides Unique Opportunity for Patent Precent Making
        9. Mexico issues regulations to approve biologic drugs
        10. Latin America Roundtable
        11. 43 more items...
      3. Copyright Law Articles
        1. When copyrights and patents collide
        2. The first balanced approach to protecting copyright online
        3. How to prevent frivolous actions
        4. Advertising in social media networks
        5. Technology challenges digital rights
        6. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        7. Derechos sobre producción audiovisual
        8. How Latin America tackles cutting-edge IP issues
        9. Copyright Litigation 2010
        10. Legislation and enforcement - Copyrights 2010
        11. 103 more items...
      4. Corporate Law Articles
        1. The International Comparative Legal Guide to: Merger Control 2012
        2. Mexico issues Personal Data Protection Rules
        3. How data affects innovation
        4. A practical cross-border
        5. New registry for security interests
        6. The International Comparative Legal Guide to: Merger Control 2011
        7. The International Comparative Legal Guide to: Merger Control 2010
        8. Due diligence issues to consider in M&A
        9. Income expectations in licensing
        10. The reasons for valuation
        11. 1 more item...
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        2. Maximising IP rights in the life sciences industry
        3. Recent amendment to the Federal Law for Consumer Protection
        4. Amendments to the Federal Law for Consumer Protection
        5. Mexico issues Personal Data Protection Rules
        6. New Regulations Pending
        7. Marketing authorization for pharmaceutical products to foreign applicants
        8. Data Package Exclusivity (DPE)
        9. Supreme Court upholds the worth of formulation patents
        10. Pharmaceutical trademarks
        11. 6 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Advertising in social media networks
        2. Whither Rental Rights?
        3. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Crossed wires: protecting medicines in Mexico
        2. Current Conditions of Use Claims in the Pharmaceutical Sector in Mexico
        3. Maximising IP rights in the life sciences industry
        4. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        5. Latin America Roundtable
        6. New regulations pending
        7. The International Comparative
        8. Approval of follow-on biologics in Mexico
        9. Global Pharmaceutical Linkage Regulations:
        10. Life Sciences Handbook 2011 - Country Q&A
        11. 5 more items...
      11. 2 more items...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Mexico's adhesion to the Madrid Protocol
      2. Intellectual Property: Past & Future
      3. Bill to diminish the life term of patents for medicaments
      4. Alejandro Luna's interview "La innovación
      5. Formulation patents included in the Linkage Gazette for the first time
      6. Mexico has signed the Anti-Counterfeiting Trade Agreement (ACTA)
      7. Mexican patent office shows intention to follow the Jurisprudence by which the Mexican Supreme Court gives clarification on how the Linkage Regulation applies to formulation patents
      8. Mexico moves forward for the recognition of Data Packaging Exclusivity in Mexico
      9. Olivares & Cía. named Mexico's Firm of the Year 2012 - Copyright
      10. Mexico subscribes Madrid Protocol
      11. 12 more items...
    5. Gazettes
      1. Mexican Linkage Gazette March 2013
      2. Mexican Linkage Gazette December 2012
      3. Mexican Linkage Gazette November 2012
      4. Mexican Linkage Gazette December 2011
      5. Mexican Linkage Gazette April 2011
      6. Mexican Linkage Gazette Aug 2010
      7. Mexican Linkage Gazette Dec 2009
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » English » Knowledge & Resources » Articles » Corporate Law Articles » Income expectations in licensing

Income expectations in licensing

By Carlos Woodworth
Managing Intellectual Property, International Briefings, June 2006
Technology transfer provides the scope for creativity in the organization and structure of what is usually a long-term relationship. The bottom line is always lasting profitability for the respective parties.
When setting a price for a technology transfer the initial objective should be to quantify the total size of the profitability pie to be generated by the combination of rights and resources which are expected to be contributed by the respective parties. There are many ways in which a licensor can realize a return on its investment in discovering, creating and developing the technology being licensed or otherwise transferred. However, a realistic approach to income expectations will facilitate a long-term relationship between the parties. It is the purpose of this briefing to outline specific criteria that should be considered to achieve a mutually satisfactory bottom line. Some of these are:
  1. Size of the relevant market: is the item resulting from the licensed technology utilized by the general public, or is it a relatively specialized item that is important to only a narrow sector of the population, or even to a limited geographical region?
  2. Dynamism of the market. This depends on the underlying sector of the economy that is expected to be caught as a result of the licence. Is it a market that is notably expanding and that may be expected to grow further? Or is this a flat market because of the excess production capacity, too many competitors or even general technological obsolesce?
  3. Characteristics of the technology to be licensed. Is the licensed technology a unique one, that is, or is expected to, create a new expanding market? Is a pioneer IP right involved? Or is it only an evolutionary refinement of something relatively standard?
  4. Quality of contribution by the owner of the technology. Does the proprietor enjoy a well-recognized reputation as an innovator and continuing source of useful ideas and improvements? Is it known to defend its rights vigorously against infringers?
  5. Assets expected to be contributed by technology recipient. Is the recipient financially capable, an efficient manufacturer, and/or does it possess a sound marketing, organization? If properly motivated, is it likely to maximize the potential of the relevant technology?
  6. General state of the economy. Are conditions considered to be healthy, expanding, in recession or in recovery? Is there an economic indicator, tax incentive, legal framework that could affect the contemplated business of the licensing parties?
Notwithstanding these basic criteria, an argument sometimes raised by a proprietor when it is offering an invention for license is that is has spent enormous time, effort and money to create and develop the technology involved. A realistic contra argument is that these are sunk costs to the licensor that are irrelevant to the licensee, who is only interested in the future profitability the licensed technology is likely to generate. The risk element is very important to determine profit sharing. Generally it is the licensee who bears the principal risk, since it is usually exposed to unknown elements in the marketplace that might help or hinder the introduction of the licensed product.
In summary, these criteria should help the parties conclude that their portion of the profit pie is not always mandated by a standard practice formula, but rather by practical approaches that might help them make a business determination when licensing technology.